Literature DB >> 30028010

PD-1 is highly expressed by neoplastic B-cells in Richter transformation.

Amir Behdad1, Brannan Griffin1, Yi-Hua Chen1, Shuo Ma2, Katalin Kelemen3, Xinyan Lu1, Qing C Chen1.   

Abstract

Entities:  

Keywords:  zzm321990chronic lymphocytic leukaemiazzm321990; PD-1 (PDCD1); PD-L1 (CD274); Richter syndrome

Mesh：

Substances：

Year:  2018        PMID： 30028010     DOI： 10.1111/bjh.15514

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  8 in total

Review 1.  Richter's Transformation.

Authors:  Audrey M Sigmund; Adam S Kittai
Journal:  Curr Oncol Rep       Date:  2022-04-06       Impact factor: 5.945

2.  Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.

Authors:  O Al-Sawaf; S Robrecht; J Bahlo; A M Fink; P Cramer; J V Tresckow; E Lange; M Kiehl; M Dreyling; M Ritgen; J Dürig; E Tausch; C Schneider; S Stilgenbauer; C M Wendtner; K Fischer; M Hallek; B Eichhorst
Journal:  Leukemia       Date:  2020-03-17       Impact factor: 11.528

3.  17p deletion strongly influences rituximab elimination in chronic lymphocytic leukemia.

Authors:  Cristina Bagacean; Adrian Tempescul; David Ternant; Anne Banet; Nathalie Douet-Guilbert; Anne Bordron; Boutahar Bendaoud; Hussam Saad; Mihnea Zdrenghea; Christian Berthou; Gilles Paintaud; Yves Renaudineau
Journal:  J Immunother Cancer       Date:  2019-01-29       Impact factor: 13.751

Review 4.  Microenvironment Remodeling and Subsequent Clinical Implications in Diffuse Large B-Cell Histologic Variant of Richter Syndrome.

Authors:  Hélène Augé; Anne-Béatrice Notarantonio; Romain Morizot; Anne Quinquenel; Luc-Matthieu Fornecker; Sébastien Hergalant; Pierre Feugier; Julien Broséus
Journal:  Front Immunol       Date:  2020-12-14       Impact factor: 7.561

5.  BET proteolysis targeted chimera-based therapy of novel models of Richter Transformation-diffuse large B-cell lymphoma.

Authors:  Warren Fiskus; Christopher P Mill; Dimuthu Perera; Christine Birdwell; Qing Deng; Haopeng Yang; Bernardo H Lara; Nitin Jain; Jan Burger; Alessandra Ferrajoli; John A Davis; Dyana T Saenz; Wendy Jin; Cristian Coarfa; Craig M Crews; Michael R Green; Joseph D Khoury; Kapil N Bhalla
Journal:  Leukemia       Date:  2021-03-02       Impact factor: 11.528

Review 6.  Novel Approaches for the Treatment of Patients with Richter's Syndrome.

Authors:  Andrea Iannello; Silvia Deaglio; Tiziana Vaisitti
Journal:  Curr Treat Options Oncol       Date:  2022-03-16

Review 7.  Biology and Treatment of Richter Transformation.

Authors:  Adalgisa Condoluci; Davide Rossi
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

Review 8.  Current Clinical Applications and Future Perspectives of Immune Checkpoint Inhibitors in Non-Hodgkin Lymphoma.

Authors:  John Apostolidis; Ayman Sayyed; Mohammed Darweesh; Panayotis Kaloyannidis; Hani Al Hashmi
Journal:  J Immunol Res       Date:  2020-10-29       Impact factor: 4.818
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.